BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2022 10:56:44 AM | Browse: 670 | Download: 1354
 |
Received |
|
2022-03-13 10:04 |
 |
Peer-Review Started |
|
2022-03-13 10:06 |
 |
First Decision by Editorial Office Director |
|
2022-04-13 11:41 |
 |
Return for Revision |
|
2022-04-13 11:41 |
 |
Revised |
|
2022-04-25 11:00 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-06-17 03:04 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-06-20 17:34 |
 |
Articles in Press |
|
2022-06-20 17:34 |
 |
Edit the Manuscript by Language Editor |
|
2022-07-25 09:06 |
 |
Typeset the Manuscript |
|
2022-09-16 05:50 |
 |
Publish the Manuscript Online |
|
2022-09-24 10:56 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Review |
| Article Title |
Association of COVID-19 with hepatic metabolic dysfunction
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ramesh Kumar, Vijay Kumar, Rahul Arya, Utpal Anand and Rajeev Nayan Priyadarshi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ramesh Kumar, MD, Associate Professor, Department of Gastroenterology, All India Institute of Medical Sciences, Patna, Phulwari Sharif, Patna 801507, Bihar, India. docrameshkr@gmail.com |
| Key Words |
COVID-19; Coronavirus; Metabolism; Metabolic syndrome; Metabolic inflammation; Hepatic dysfunction |
| Core Tip |
In coronavirus disease 2019 (COVID-19) patients, the virus induces a complex viral-host interaction that leads to metabolic reprogramming, altered immunological responses, and a variety of clinical consequences. In metabolomic and lipidomic studies, a variety of alterations in amino acids, lipids, carbohydrates, and energy metabolism have been identified in such patients. The liver is the primary metabolic organ; thus, these metabolic alterations may have a major impact on patients with liver diseases and metabolic comorbidities that are common in COVID-19 patients. Therefore, this review article discusses the pathophysiological aspects and clinical implications of metabolic dysfunction in COVID-19 patients with a focus on the liver. |
| Publish Date |
2022-09-24 10:56 |
| Citation |
Kumar R, Kumar V, Arya R, Anand U, Priyadarshi RN. Association of COVID-19 with Hepatic Metabolic Dysfunction. World J Virol 2022; 11(5): 237-251 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i5/237.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i5.237 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.